Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T18:47:35.195Z.
Calculation as of: 2026-10-06T18:47:35.195Z.
Quote observation: 2026-10-06T18:45:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 66afd7ad6fe085f612ae866be6517f9e897c4fba6e73e474a8e5d595bf17d99d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$3.21B
PS Ratio
5.29
TTM Avg
6.87
3Y Avg
18.81
5Y Avg
18.14
Market Cap
$3.44B
PS Ratio
2900.67
TTM Avg
5949.66
3Y Avg
5949.66
5Y Avg
2255.37
Market Cap
$3.49B
PS Ratio
14.89
TTM Avg
44.87
3Y Avg
169.56
5Y Avg
109.21
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | $3.33B | N/A | N/A | N/A | N/A |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.32B | N/A | N/A | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.38B | 7.38 | 3.47 | 3.09 | 3.52 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 2.98 | 3.85 | 3.95 | 5.00 |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.21B | 5.29 | 6.87 | 18.81 | 18.14 |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 2900.67 | 5949.66 | 5949.66 | 2255.37 |
| Celcuity Inc. (CELC)vs › | $3.49B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | 14.89 | 44.87 | 169.56 | 109.21 |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.53B | 65.51 | 43.40 | 26.92 | 23.78 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.51B | N/A | 436.18 | 3953.03 | 1750.10 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
